We are live on ! Find out more
ENTXW

Entera Bio Ltd. Warrant
ENTXW

Delisted

ENTXW was delisted on the 27th of June, 2023.

Back to rankings

2 hedge funds and large institutions have $40K invested in Entera Bio Ltd. Warrant in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

52% less capital invested

Capital invested by funds: $83K → $40K (-$43K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$123

Top Sellers

Rank Fund Capital Flow
1
WVP
Worth Venture Partners
New Jersey
-$93.1K
2
UBS Group
UBS Group
Switzerland
-$739

ENTXW Hedge Fund Activity: Q3 2020 in Review

2 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Entera Bio Ltd. Warrant (ENTXW) for Q3 2020, worth a combined $40K — down 52% from $83K a quarter earlier.

Fund positioning in ENTXW was balanced in Q3 2020: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $123. The largest seller was Worth Venture Partners, exiting entirely with an estimated $93.1K sold.

  • 2 institutional investors held Entera Bio Ltd. Warrant (ENTXW) as of Q3 2020, unchanged from Q2 2020.
  • Funds reported $40K of Entera Bio Ltd. Warrant stock for Q3 2020, down 52% quarter-over-quarter.
  • 1 fund opened new Entera Bio Ltd. Warrant positions in Q3 2020 and 1 closed out, a net change of 0 holders.
  • The largest Entera Bio Ltd. Warrant buyer in Q3 2020 was Morgan Stanley, an estimated $123 added.
  • The largest Entera Bio Ltd. Warrant seller in Q3 2020 was Worth Venture Partners, an estimated $93.1K sold.

Based on aggregated 13F filings for Q3 2020.